IBDEI1JX ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,24800,1,3,0)
 ;;=3^Hypergammaglobulenemia,Unspec
 ;;^UTILITY(U,$J,358.3,24800,1,4,0)
 ;;=4^D89.2
 ;;^UTILITY(U,$J,358.3,24800,2)
 ;;=^5002455
 ;;^UTILITY(U,$J,358.3,24801,0)
 ;;=D05.12^^107^1211^94
 ;;^UTILITY(U,$J,358.3,24801,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24801,1,3,0)
 ;;=3^Intraductal Carcinoma in Situ,Left Breast
 ;;^UTILITY(U,$J,358.3,24801,1,4,0)
 ;;=4^D05.12
 ;;^UTILITY(U,$J,358.3,24801,2)
 ;;=^5001931
 ;;^UTILITY(U,$J,358.3,24802,0)
 ;;=D05.11^^107^1211^95
 ;;^UTILITY(U,$J,358.3,24802,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24802,1,3,0)
 ;;=3^Intraductal Carcinoma in Situ,Right Breast
 ;;^UTILITY(U,$J,358.3,24802,1,4,0)
 ;;=4^D05.11
 ;;^UTILITY(U,$J,358.3,24802,2)
 ;;=^5001930
 ;;^UTILITY(U,$J,358.3,24803,0)
 ;;=D05.10^^107^1211^96
 ;;^UTILITY(U,$J,358.3,24803,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24803,1,3,0)
 ;;=3^Intraductal Carcinoma in Situ,Unspec Breast
 ;;^UTILITY(U,$J,358.3,24803,1,4,0)
 ;;=4^D05.10
 ;;^UTILITY(U,$J,358.3,24803,2)
 ;;=^5001929
 ;;^UTILITY(U,$J,358.3,24804,0)
 ;;=D50.0^^107^1211^97
 ;;^UTILITY(U,$J,358.3,24804,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24804,1,3,0)
 ;;=3^Iron Deficiency Anemia Secondary to Blood Loss
 ;;^UTILITY(U,$J,358.3,24804,1,4,0)
 ;;=4^D50.0
 ;;^UTILITY(U,$J,358.3,24804,2)
 ;;=^267971
 ;;^UTILITY(U,$J,358.3,24805,0)
 ;;=D50.9^^107^1211^98
 ;;^UTILITY(U,$J,358.3,24805,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24805,1,3,0)
 ;;=3^Iron Deficiency Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,24805,1,4,0)
 ;;=4^D50.9
 ;;^UTILITY(U,$J,358.3,24805,2)
 ;;=^5002283
 ;;^UTILITY(U,$J,358.3,24806,0)
 ;;=C46.9^^107^1211^99
 ;;^UTILITY(U,$J,358.3,24806,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24806,1,3,0)
 ;;=3^Kaposi's Sarcoma,Unspec
 ;;^UTILITY(U,$J,358.3,24806,1,4,0)
 ;;=4^C46.9
 ;;^UTILITY(U,$J,358.3,24806,2)
 ;;=^5001108
 ;;^UTILITY(U,$J,358.3,24807,0)
 ;;=C22.0^^107^1211^100
 ;;^UTILITY(U,$J,358.3,24807,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24807,1,3,0)
 ;;=3^Liver Cell Carcinoma
 ;;^UTILITY(U,$J,358.3,24807,1,4,0)
 ;;=4^C22.0
 ;;^UTILITY(U,$J,358.3,24807,2)
 ;;=^5000933
 ;;^UTILITY(U,$J,358.3,24808,0)
 ;;=D05.02^^107^1211^101
 ;;^UTILITY(U,$J,358.3,24808,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24808,1,3,0)
 ;;=3^Lobular Carcinoma in Situ,Left Breast
 ;;^UTILITY(U,$J,358.3,24808,1,4,0)
 ;;=4^D05.02
 ;;^UTILITY(U,$J,358.3,24808,2)
 ;;=^5001928
 ;;^UTILITY(U,$J,358.3,24809,0)
 ;;=D05.01^^107^1211^102
 ;;^UTILITY(U,$J,358.3,24809,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24809,1,3,0)
 ;;=3^Lobular Carcinoma in Situ,Right Breast
 ;;^UTILITY(U,$J,358.3,24809,1,4,0)
 ;;=4^D05.01
 ;;^UTILITY(U,$J,358.3,24809,2)
 ;;=^5001927
 ;;^UTILITY(U,$J,358.3,24810,0)
 ;;=D05.00^^107^1211^103
 ;;^UTILITY(U,$J,358.3,24810,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24810,1,3,0)
 ;;=3^Lobular Carcinoma in Situ,Unspec Breast
 ;;^UTILITY(U,$J,358.3,24810,1,4,0)
 ;;=4^D05.00
 ;;^UTILITY(U,$J,358.3,24810,2)
 ;;=^5001926
 ;;^UTILITY(U,$J,358.3,24811,0)
 ;;=R59.0^^107^1211^62
 ;;^UTILITY(U,$J,358.3,24811,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24811,1,3,0)
 ;;=3^Enlarged Lymph Nodes,Localized
 ;;^UTILITY(U,$J,358.3,24811,1,4,0)
 ;;=4^R59.0
 ;;^UTILITY(U,$J,358.3,24811,2)
 ;;=^5019529
 ;;^UTILITY(U,$J,358.3,24812,0)
 ;;=C83.59^^107^1211^104
 ;;^UTILITY(U,$J,358.3,24812,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24812,1,3,0)
 ;;=3^Lymphoblastic Lymphoma,Extranodal/Solid Organ Sites
